Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
本季度可能拯救您的投资组合的三大医疗保健股票
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
医疗保健领域超卖次数最多的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI 是一种动量指标，它比较股票在价格上涨的日子和价格下跌的日子的走势。与股票的价格走势相比，它可以让交易者更好地了解股票在短期内的表现。根据Benzinga Pro的数据，当相对强弱指数低于30时，资产通常被视为超卖。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是该行业主要超卖参与者的最新名单，RSI接近或低于30。
Verve Therapeutics Inc (NASDAQ:VERV)
Verve Therapeutics Inc（纳斯达克股票代码：VERV）
- On April 2, Verve Therapeutics announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in patients with a genetic condition that leads to high cholesterol levels, which raises the risk of heart disease. The treatment is supposed to permanently turn off a protein called PCSK9, which helps reduce blood cholesterol levels. The company's stock fell around 44% over the past month and has a 52-week low of $7.36 .
- RSI Value: 25.88
- VERV Price Action: Shares of Verve Therapeutics fell 8.5% to close at $8.01 on Wednesday.
- 4 月 2 日，Verve Therapeutics 宣布了 VERVE-101 的 Heart-1 1b 期试验的最新进展。正在对患有导致高胆固醇水平的遗传病患者进行 VERVE-101 评估，这会增加患心脏病的风险。该疗法本应永久关闭一种叫做 PCSK9 的蛋白质，它有助于降低血液中的胆固醇水平。该公司的股票在过去一个月中下跌了约44％， 52 周低点为 7.36 美元 。
- RSI 值：25.88
- VERV价格走势：周三，Verve Therapeutics的股价下跌8.5％，收于8.01美元。
UnitedHealth Group Inc (NYSE:UNH)
联合健康集团公司（纽约证券交易所代码：UNH）
- On April 10, TD Cowen analyst Gary Taylor maintained UnitedHealth with a Buy and lowered the price target from $607 to $546.. The company's stock fell around 8% over the past month. It has a 52-week low of $445.68.
- RSI Value: 27.67
- UNH Price Action: Shares of UnitedHealth fell 2.1% to close at $450.05 on Wednesday.
- 4月10日，道明考恩分析师加里·泰勒维持UnitedHealth的买入，并将目标股价从607美元下调至546美元。该公司的股票在过去一个月中下跌了约8％。它 创下 52 周低点 为445.68美元。
- RSI 值：27.67
- UNH价格走势：周三，UnitedHealth的股价下跌2.1％，收于450.05美元。
Gilead Sciences, Inc. (NASDAQ:GILD)
吉利德科学公司（纳斯达克股票代码：GILD）
- On April 8, Gilead Sciences said it will release its first quarter 2024 financial results and guidance on Thursday, April 25, 2024, after the closing bell.. The company's stock fell around 10% over the past month and has a 52-week low of $68.06.
- RSI Value: 27.43
- GILD Price Action: Shares of Gilead Sciences fell 2.6% to close at $68.12 on Wednesday.
- 4月8日，吉利德科学表示，将在收盘后于2024年4月25日星期四发布其2024年第一季度财务业绩和指导。该公司的股票在过去一个月中下跌了约10％，为期52周 低点为68.06美元。
- RSI 值：27.43
- GILD价格走势：周三，吉利德科学股价下跌2.6％，收于68.12美元。